PROJECT INFORMATION
GOLD Project ID
Gp0685508  
Project Name
Chlamydia abortus MRI-10/19  
Other Names
  
Legacy GOLD ID
  
NCBI BioProject Name Chlamydia abortus MRI-10/19
NCBI BioProject Accession PRJNA700999
NCBI Locus Tag
JS522  
NCBI BioSample Accession SAMN17842858
Source Sample ID
PI Unknown
Added By JGI automated process on 2022-09-29
Last Modified By JGI automated process on 2022-10-05
Project Comments
  
Project Status
Complete and Published  
Project Relevance Agricultural
Sequencing Center Moredun Research Institute (United Kingdom)
Collaborating Institute
  
Funding Agency
  
Project Description
Chlamydia abortus MRI-10/19 genome sequencing  
Is JGI Project
No  
Project Information Visibility Public
PROJECT TYPE
Specimen Organism
Nucleic Acid DNA
Sequencing Strategy
Whole Genome Sequencing  
EXTERNAL PROJECT LINKS
JGI Data Utilization Status
  
JGI Award DOI
Genome Publications PloS one: 15(11):e0242526 The 1B vaccine strain of Chlamydia abortus produces placental pathology indistinguishable from a wild type infection.
PubMed: 33196660 DOI: 10.1371/journal.pone.0242526
Other Publications
  
Ignored Publications
  
Unassigned Publications
  
SRA Experiment
 
SRA Experiment Id SRX10074216  (Link to NCBI )
Experiment Title Nanopore sequencing of Chlamydia abortus MRI-10/19
Exp Library Strategy WGS
Library Source GENOMIC
Library Selection RANDOM
Library Name MRI-10/19_Nanopore
Library Layout SINGLE
Library Instrument MIN_ION
 
SRA Experiment Id SRX10074215  (Link to NCBI )
Experiment Title Illumina sequencing of Chlamydia abortus MRI-10/19
Exp Library Strategy WGS
Library Source GENOMIC
Library Selection RANDOM
Library Name MRI-10/19_Illumina
Library Layout PAIRED
Library Instrument ILLUMINA_HI_SEQ_2500
PROJECT COMPOSITION
Study Whole genome sequence of Chlamydia abortus MRI-10/19
Organism Chlamydia abortus MRI-10/19
Analysis Projects Chlamydia abortus MRI-10/19
Number of Analysis Projects (AP) 1
Number of Derived Analyis Projects (DAP)
0  
SEQUENCING INFORMATION
Sequencing Status Complete
Sequencing Quality (MIGS-31) Level 6: Finished
Finishing Goal
Contamination Screening Input
  
DNA Amplification Method
  
Single Cell Lysis Protocol
  
Single Cell Lysis Approach
  
Sequencing Comments
  
DNA Amplification Kit
  
Sequencing Technology (MIGS-29) Illumina HiSeq; Oxford Nanopore MinION
Library Method (MIGS-28)
  
Library Layout
  
Library Screening Method
  
Number Of Reads
  
Read Size
  
Vector
  
GC Percent
  
Chromosome Count
  
Plasmid Count
  
ORGANISM NAME
GOLD Organism ID Go0649409
Organism Name
Chlamydia abortus MRI-10/19  
Other names (alias, synonyms, short names, common names)
  
Organism Domain
BACTERIAL  
Phylogeny
CHLAMYDIOTA  
Genus
Chlamydia  
Genus Synonyms
  
Species
Chlamydia abortus  
Subspecies
  
Species Synonyms
  
Strain
MRI-10/19  
Strain Synonyms
  
Serovar/Cultivar
  
Culture Collection ID
  
Type Strain
  
Exemplar DOI
  
Exemplar Name
  
Taxon DOI
  
Biosafety Level
  
Organism Comments
  
Cultured
Yes  
Culture Type
Isolate  
Organism Type
Natural  
Uncultured Type
  
Commercial Strain
  
Commercial Strain Comments
  
ORGANISM TAXONOMY
NCBI Taxonomy ID 83555
NCBI Superkingdom
Bacteria  
NCBI Kingdom
  
NCBI Phylum
Chlamydiota  
NCBI Class
Chlamydiia  
NCBI Order
Chlamydiales  
NCBI Family
Chlamydiaceae  
NCBI Genus
Chlamydia  
NCBI Species
Chlamydia abortus  
ISOLATION CLASSIFICATION
Ecosystem
Host-associated  
Ecosystem Category
Unclassified  
Ecosystem Type
Unclassified  
Ecosystem Subtype
Unclassified  
Specific Ecosystem
Unclassified  
ORGANISM EXTERNAL REFERENCES
Strain Info ID
Genbank 16S ID
GENERAL PROPERTIES
Oxygen Requirement
  
Cell Shape
  
Motility
  
Sporulation
  
Temperature Range
  
Salinity
  
pH
  
Cell Diameter
  
Cell Length
  
Color
  
Gram Staining
  
Biotic Relationships
  
Symbiotic Physical Interaction
  
Symbiotic Relationship
  
Symbiont Name
  
Symbiont Taxon ID
  
Cell Arrangements
  
Diseases
  
Known Habitats
  
Metabolisms
  
Phenotypes
  
Energy Sources
  

 

 

  You are going to add the following user to your project, biosample and study.

 

Contact Name/Email:

Do you want to continue?

 

 

  You are going to remove permissions for the following user to your project, biosample and study.

 

Contact Name/Email:

Do you want to continue?

 

 

  Changing the SP visibility will also change visibility on the following items:

 

Do you want to continue with this visibility change?

 

 

  Checking that this Sequencing Project can be made private:

 

Do you want to continue with this visibility change?

 

 

 

 

 

  Changing the SP Sequencing Strategy will also effect these items:

 

Do you want to continue with this Sequencing Strategy change?